InvestorsHub Logo
Followers 51
Posts 9182
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Monday, 06/13/2022 11:41:27 PM

Monday, June 13, 2022 11:41:27 PM

Post# of 13572
Goldman Sachs Likes These 2 Beaten-Down Stocks for Triple-Digit Upside:

“We expect shares to rise on an announcement of US government purchasing of new vaccines for the fall as it would show the potential for upside to MRNA’s estimated ~$21bn in Advance Purchase Agreements (APAs),” the 5-star analyst explained. “Broadly, we believe investors are underestimating the optionality of MRNA’s platform which has been significantly de-risked by the billions of vaccinations given over the past two years using mRNA technology.”


Richter, though, is anticipating a meaningful recovery; the analyst has a Buy rating for the shares backed by a $290 price target.

https://finance.yahoo.com/news/goldman-sachs-likes-2-beaten-223920027.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News